Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-052285

Chief Product Officer gave up 577 shares (to pay taxes)

  • Chief Product Officer acquired 1,964 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Besch Doug Chief Product Officer 2024-12-19 Option exercise +1,964 12,160 D
Besch Doug Chief Product Officer 2024-12-19 Shares withheld for taxes −577 $4.75 $2,741 11,583 D
Derivatives
Besch Doug Chief Product Officer 2024-12-19 Option exercise · Restricted Stock Units −1,964 3,928 D
Loading xslF345X05/wk-form4_1734742023.xml…